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This descriptive and exploratory study analyzed variables associated with health-related 
quality of life among 130 outpatients. Health-related quality of life was measured through 
the Minnesota Living with Heart Failure Questionnaire. Significant associations were found 
between patients’ health-related quality of life and their age (r=-0.177; p=0.044), vitality 
(r=-0.625; p=<0.001) as well as mental health (r=-0.672; p=<0.001), which are both SF-
36 domains. The linear regression showed that heart failure symptom severity, vitality and 
mental health explained 54% of HRQOL measurement variation. To control symptoms and 
preserve good mental well-being are important to maintain health-related quality of life and 
to deliver effective heart failure care.
Descriptors: Heart Failure; Quality of Life; Mental Health; Symptoms.
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Determinantes da qualidade de vida relacionada à saúde em pacientes 
ambulatoriais com insuficiência cardíaca
Trata-se de estudo descritivo e exploratório que analisou as variáveis associadas à 
qualidade de vida relacionada à saúde (QVRS), de 130 pacientes com insuficiência 
cardíaca, em seguimento ambulatorial. A QVRS foi avaliada pelo Minnesota Living with 
Heart Failure e realizada análise de regressão linear. A média da QVRS foi de 34,9 
(dp=24,8; intervalo de 0 a 99). Foram encontradas associações significantes entre a 
medida da QVRS e idade (r=-0,177; p=0,044), vitalidade (r=-0,625; p=<0,001) e saúde 
mental (r=-0,672; p=<0,001), domínios do SF-36. A regressão linear mostrou que a 
gravidade dos sintomas da insuficiência cardíaca, e dois domínios do SF-36, vitalidade e 
saúde mental, explicaram 54% da variação da medida da QVRS. Controlar os sintomas e 
manter bem-estar mental é essencial para a manutenção da QVRS e são essenciais para 
o cuidado eficaz da insuficiência cardíaca.
Descritores: Insuficiência Cardíaca; Qualidade de Vida; Saúde Mental; Sintomas.
Determinantes de la calidad de vida relacionada a la salud en pacientes 
atendidos en ambulatorios con insuficiencia cardíaca
Se trata de un estudio descriptivo y exploratorio que analizó las variables asociadas a la 
calidad de vida relacionada a la salud (CVRS) de 130 pacientes con insuficiencia cardíaca 
en seguimiento en ambulatorio. La CVRS fue evaluada por el Minnesota Living with 
Heart Failure y realizado análisis de regresión linear. El promedio de la CVRS fue de 34,9 
(DE = 24,8; intervalo de 0 a 99). Fueron encontradas asociaciones significantes entre 
la medida de la CVRS y edad (r=-0,177; p=0,044), vitalidad (r=-0,625; p=<0,001) y 
salud mental (r=-0,672; p=<0,001), dominios del SF-36. La regresión linear mostró 
que la gravedad de los síntomas de la Insuficiencia Cardíaca, y dos dominios del SF-
36, vitalidad y salud mental, explicaron 54% de la variación de la medida de la CVRS. 
Controlar los síntomas y mantener el bienestar mental es esencial en la manutención de 
la CVRS y son esenciales para el cuidado eficaz de la Insuficiencia Cardíaca.
Descriptores: Insuficiencia Cardíaca; Calidad de Vida; Salud Mental; Síntomas.
Introduction
Heart Failure (HF) has been an increasing public 
health problem in developed countries. Its increase 
is usually associated with population age, the wide 
prevalence of cardiovascular risk factors and other 
diseases. HF is associated with complications like 
obesity and diabetes, and improved survival rates from 
myocardial infarction(1).
HF is also a growing concern in developing countries. 
In Brazil, HF affects over two million people, with 240,000 
new diagnoses per year(2). HF is present in one third of 
patients who are treated by the public health system 
in Brazil, which mostly attends the country’s oldest and 
poorest people. HF is the main cause of heart-related 
hospitalizations in the public health system (293,759 
admissions in 2007), with an annual mortality rate 
of about 8% and approximately 23,442 deaths each 
year(2).
Heart failure patients face a wide variety of 
symptoms that can adversely impact their quality of life. 
Physical and psychological symptoms are widely reported. 
Patients with heart failure face significant decreases in 
functional status, multiple hospital admissions, high 
mortality, multiple physical and psychological symptoms 
and a diminished quality of life(3).
It is well known that HF significantly worsens health-
related quality of life (HRQOL) by reducing patients’ 
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functional capacity and ability to perform activities of 
daily living. HRQOL encompasses various aspects of self-
perceived well-being, which are related to or affected by 
the presence of a disease and/or treatment(3).
The effects on HRQOL size are influenced by many 
factors, including patient age, gender, left ventricular 
dysfunction, New York Heart Association (NYHA) 
functional class, HF severity, mortality risk and mental 
health(3-4). Heart failure patients face a wide variety of 
physical (dyspnea, fatigue, pain, edema, loss of appetite) 
and psychological (anxiety and depression) symptoms 
that can adversely impact their quality of life(3). Female 
patients tend to report more physical limitations and 
depressive symptoms compared with male patients(5).
In combination, these factors place severe 
limitations on their daily living activities and have 
adverse effects on physical and mental health and 
perceived quality of life. For example, fatigue reduces 
autonomy and independence for daily activities(6). 
However, though quality of life is measureable, it is also 
a complex and multi-faceted construct that is prone to 
cultural and social differences. To date, HRQOL during 
HF has been studied mostly in the United States(7-10), 
Canada(11) Europe(12-14) and Asia(15). Due to a lack of 
studies, little is known about how HF influences HRQOL 
in South American populations(16-17).
This study was guided by the question: “What 
are the associations among health-related quality of 
life, demographic and clinical variables in heart failure 
outpatients followed at a public hospital in Brazil?”
To address this knowledge gap, this study sought 
to identify the predictors of Health-related quality of life 
in heart failure patients followed at a public hospital in 
Brazil.
Method
Design, setting and subjects
A larger study that used an observational cross-
sectional design was based at the University Hospital, 
Hospital das Clínicas in Ribeirão Preto, São Paulo state, 
which attends a mixed rural and urban population all over 
the Southeastern region of Brazil. Approval for the study 
was obtained from the Institutional Review Board at the 
School of Medicine. Participants were recruited from the 
Cardiology Division of the University Hospital. Eligible 
participants were recruited from a single specialty HF 
clinic in the hospital. Inclusion criteria included people 
aged 18 years or older, HF diagnosis based on clinical 
signs, radiological, and echocardiography findings, 
and a medical visit at the Cardiomyopathy Specialized 
Clinic of the University Hospital during the study period. 
Exclusion criteria included the presence of neurological 
disorder, major psychiatric condition (such as dementia 
or schizophrenia), or cognitive impairment.
The enrollment period ranged from February 2005 
to August 2006, 138 patients were invited to participate 
in the study. Two patients declined to participate and 
6 patients could not participate due to their physical, 
psychological or cognitive conditions. Overall, a 
convenience sample of 130 patients was analyzed in the 
study.
Data collection and instruments
Data were collected immediately after the 
individual’s medical visit. Other clinical data were 
obtained through a review of patients’ medical records. 
To test comprehension and relevance of data collection 
instruments, a pilot test was performed on ten subjects. 
As no changes were necessary, those patients were 
included in the final sample.
The instruments used to measure the variables 
were the following:
- Health-related quality of life: it was measured using 
the total score of the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ)(8). The MLHFQ total scale ranged 
from zero to 105, with lower scores meaning better 
HRQOL. This measurement tool is reliable and valid(3). 
The Portuguese version of the MLHFQ(17) was used and 
the internal consistency for the total scale was 0.93 in 
the present study.
- Perceived mental health status: it was measured using 
the two domains from the Medical Outcomes Study SF-
36: mental health (psychological distress and well-being) 
and vitality (energy and fatigue)(18). In a possible range 
from zero to 100, higher scores reflect better health 
perception in both domains. The SF-36(19) Portuguese 
translation was culturally adapted to Brazil and it was 
found reliable and valid in HF patients(16). Hence, it was 
also used.
- Other Variables: Demographic data collected during 
the interview included age, gender, educational level 
(in years), marital status (married/have a partner 
versus not), and work status (having a paid job versus 
not). Clinical data were: HF etiology, length of follow-
up for HF disease (in years). Left Ventricular Ejection 
Fraction (LVEF) echocardiography test was analyzed to 
measure left ventricular dysfunction, New York Heart 
Association Functional Class (NYHA-FC I, II, III e IV) 
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to measure HF symptoms, number of co-morbidities, 
number of medications prescribed, and artificial 
pacemaker presence or resynchronization therapy. 
Clinical variables were also grouped: LVEF (less than 
30% and between 30% and 44%); and the NYHA-
Functional Class (class I for asymptomatic HF and 
classes II to IV for symptomatic HF).
Data analysis
The data were analyzed using the statistical 
software SPSS (Statistical Package for Social Science 
version 15.0). Descriptive analysis was performed for all 
variables. To assess the association of demographic and 
clinical variables to HRQOL, univariate analyses based 
on Pearson’s correlation was calculated for numerical 
variables. For categorical explanatory variables, 
Student’s t test was performed to assess differences in 
mean MLHFQ total score among the categories. Pearson’s 
correlations were calculated between the continuous 
variables (age, educational background, follow-up HF 
disease length of time, and Left Ventricular Ejection 
Fraction) and HRQOL (measured by MLHFQ total score). 
Linear regression analysis using a stepwise regression 
model was performed for multivariate investigation 
of the association between the HRQOL measure and 
demographic, clinical, and perceived mental health 
variables. Age and gender were considered factors that 
were a prior presence in HF and were controlled before 
clinical variables. The significance level was 0.05.
Results
One hundred and thirty patients were included. 
Their average age was 55.1 (s.d. = 14.9) and most 
of them were less than 60 years old (78; 60%). The 
majority was male (n=77, 59.2%), married or living 
with a partner (80, 61.5%), they had a low education 
level (four years of formal study on average), and no 
paid employment (107, 82.3%) (Table 1).
The patients’ length of inclusion into the specialty 
HF clinic was 1.5 years on average, ranging from zero 
(i.e. patients who were beginning the follow-up on the 
day of the interview) to 4.8 years. Most of the patients 
(80; 61.6%) were symptomatic in NYHA-Functional 
Class II-IV. The mean LVEF was 27% (s.d. = 29; 
range from 10% to 43%); 46.9% had severe LVEF and 
32.3% had moderate LVEF dysfunction. Twenty-one 
patients (15.4%) had an artificial pacemaker due to 
bradycardia and none of them had resynchronization 
therapy (Table 1).
Fifty-nine participants (44.3%) reported at least 
one comorbidity, and 86 (47%) participants showed 
associated diseases, such as: systemic arterial 
hypertension, chronic atrial fibrillation, arrhythmias, and 
hyperthyroidism. Among the participants, there was a 
large variation regarding medication uses, with subjects 
using from one to ten different classes of medication 
(mean=5.8 e s.d. =1.8). The most common medications 
used by the patients and reported in the medical records 
were diuretics, Angiotensin-converting enzyme, Beta-
blockers and digitalis.
Table 1 - Characteristics of sample (n=130)
Characteristics Mean (s.d.) or n (%)
Age 55.1 (14.9%)
Less than 60 78 (60.0%)
60 or more 52 (40.0%)
Male 77 (59.2%)
Marital Status (married/partnered) 80 (61.5%)
Educational background (years) 3 (3.9%)
Work status (having no paid job) 107 (82.3%)
length of HF follow-up (in years) 1.5 (1.4%)
Functional Class (NYHA)
I (asymptomatic) 49 (37.7%)
II/III or IV (symptomatic) 80 (61,6%)
not informed 1 (0.7%)
Left Ventricular Ejection Fraction 27% (29%)
less than 30% (severe dysfunction) 61 (46.9%)
from 30 to 40% (moderate) 42 (32.3%)
not informed 27 (20.8%)
Pacemaker presence (yes) 21(15.4%)
Regarding HRQOL, the mean MLHFQ was: 34.9 
(s.d. = 24.8; range from 0 to 99). The association 
between HRQOL and age was negative and weak (r=-
0.177; p=0.044), although statistically significant. Weak 
associations were found between HRQOL and length of 
HF follow-up (r=-0.233; p=0.015), as well as HRQOL and 
left ventricular ejection fraction (r=-0.236; p=0.017) 
(Table 2). No association was found between HRQOL and 
educational background (r=0.004; p=0.960). However, 
Perceived Mental Health, the exploratory variable of 
interest, measured by the vitality (r=-.625, p<0.001) 
and mental health domains (r=-0.672, p<0.001) of 




Pelegrino VM, Dantas RAS, Clark AM.
Table 2 - Zero order correlation between HRQOL (MLHFQ 
total score) and explanatory variables
Explanatory variables  r*  p-value†
Age (years) -0.177 .044
Educational background (years) 0.004 .960
Length of HF follow-up (years) -.0213 .015
Left Ventricular Ejection Fraction -0.236 .017
Vitality (SF-36 domain) -0.625 <.001
Mental Health (SF-36 domain) -0.672 <.001
* Pearson’s correlation; † p-value
No association was found between HRQOL and 
demographic variables. Although younger and female 
patients had higher MLHFQ Total scores (indicating 
perception of more negative HF effects on quality of 
life) than older and male patients, differences were 
not significant (p=0.092 and p=0.052, respectively). 
Nor did HRQOL vary based on marital status (Table 
3). Health-related quality of life was significantly lower 
in patients with worse symptoms (NYHA Class II, III 
and IV; p<0.001) but non-significant differences were 
associated with severe left ventricular dysfunction (less 
than 30%; p=0.054) (Table 3).
The multivariate analysis was performed using 
a two-stepwise regression model, constructed first by 
entering NYHA Classification and then Mental Health 
and Vitality into the model. After entering the first step, 
Table 3 - Mean of MLHFQ total scale by Categorical 
Explanatory Variables
Explanatory variables Mean (s.d.) p-value*
Gender
0.092 Female 39.3 (23.3)
 Male 31.8 (25.4)
Age (years)
0.052 Less than 60 38.3 (25.6)
 60 or more 29.7 (22.7)
Marital status
0.869
 Married/living with significant other 35.4 (25.7)
 Widowed/Divorced/Separated/Single 34.6 (23.5)
Functional Class (NYHA)
<0.001 I (asymptomatic) 21.0 (16.7)
 II/III or IV (symptomatic) 42.7 (23.9)
Left Ventricular Ejection Fraction
0.054 Less than 30% (severe dysfunction) 39.6 (26.6)
 From 30 to 40% (moderate) 29.8 (22.2)
* p-value from Student’s t test
Table 4 - Regression Analysis MLHFQ total score as the Outcome
Explanatory Variable Coefficient St. Error p-value* r2 † p-value‡
STEP 1
NYHA Functional Class (ref.: Class I)
Classes II, III, IV 0.460 4.537 0.00 0.204 0.00
STEP 2:
NYHA Functional Class 0.300 3.764 0.00
Mental Health -0.566 .78 0.00 0.496 0.00
STEP 3:
NYHA Functional Class 0.208 3.725 0.00
Mental Health -0.477 .096 0.00
Vitality -0.195 .104 0.33 0.541 0.00
the adjusted r2 was 0.204. Hence, the presence of HF 
symptoms explained, by itself, about 20% of variance 
in the HRQOL measure. When adding Mental Health and 
Vitality scales, R2 increased to 0.496 (49% of the HRQOL 
variance) and this increase was statistically significant 
(p-values <0.001). The final model explained 54% of 
total MLHF scale variation and, also, vitality and mental 
health together with NYHA Functional Class explained 
34% of variance (Table 4).
* p-value from Student’s t test; † Pearson’s correlation; ‡ p-value
Discussion
The contribution of perceived mental health 
(measured by Vitality and Mental Health SF-36 
subscales) to explain the variance in HRQOL was high 
(31%) after adjusting for demographic and clinical 
variables. This is consistent with results usually obtained 
from observational studies in clinical research(14). These 
results support the hypothesis that symptom severity 
and psychological factors (such as mood, depression 
and anxiety) significantly contribute to HRQOL in HF 
patients(9-10,20). The levels of HRQOL in our study were 
similar to those found in other patients with HF in 
Brazil(16,19,21) and in the USA(5,10,14).
The participants in this study were predominantly 
less than 60 years old, male, married, with low 
educational level and without paid employment. Most of 
the patients were symptomatic, and they were classified 
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as having severe LVEF or moderate LVEF dysfunction. 
Among the participants, lower HRQOL was associated 
with severity of HF symptoms (NYHA functional Classes 
II, III e IV), and severe left ventricular dysfunction. 
These findings are consistent with studies undertaken 
in the United Kingdom(14) and the United States(4,7-8). In 
line with other studies, younger patients and women 
had lower HRQOL(3-4), but there was no association with 
marital status. Physical symptom status was the most 
powerful predictor of HRQOL in patients with heart 
failure(22).
The patients in this study primarily had a lower 
socio-economic status and showed high levels of low 
literacy, but this is typical for patients treated in Brazilian 
public hospitals(16,19,21-23). The HF sample was also similar 
to populations from other studies in Brazil(16,21,24). 
Although samples used in other studies from the USA(8,25) 
and Spain(20) showed similar characteristics, most of the 
samples have considerably higher socio-economic and 
educational levels. In the future, we propose including 
this kind of population in a new study in order to improve 
our knowledge about that population’s health.
The impact of HF symptoms is both physical and 
psychosocial and how to manage these symptoms 
effectively is a cornerstone of HF management success 
and self-care(3,10). Given the importance of HRQOL 
to patients, the adaptation of disease management 
interventions to support effective self-care of HF in Brazil 
is a priority(16-17,24). Programs to support self-care should 
include both patients and partners and examine ways to 
ensure that the many facets of these interventions are 
accessible and beneficial to patients with very low socio-
economic and educational levels(9,24-25).
These results suggest that the development and 
provision of interventions to improve psychological status 
may improve physical symptom status and HRQOL in HF 
patients(22). Those most at risk for diminished quality of 
life are those of younger age, worse functional status, 
increased symptom prevalence and increased symptom 
burden(3). Though provision of these therapies to the larger 
population with depressive symptoms will be costly, this 
may be offset via reduced re-hospitalization rates, which 
are also common in HF patients from Brazil.
Conclusion
Regarding the effects of HF on HRQoL, there was 
a weak association between HRQoL and the length of 
HF follow-up, as well as between HRQoL and the left 
ventricular ejection fraction. However, Perceived Mental 
Health, the exploratory variable of interest, measured by 
the vitality and mental health domains of the SF-36, was 
significantly associated with HRQoL. The contribution 
of perceived mental health to explain the variance in 
HRQoL was higher after adjusting for demographic and 
clinical variables. These results support the hypothesis 
that symptom severity and psychological factors 
significantly contribute to improve HRQoL in HF patients. 
Our findings indicated the importance of keeping control 
of HF symptoms and mental health improvement.
The study is limited by its cross-sectional design and 
limitations regarding the number of variables that could 
be measured. Further, longitudinal studies are needed 
to examine the influence of clinical and psychosocial 
dimensions on HRQoL across the HF trajectory. Our 
results suggest that interventions tailored to improve 
self-perceived vitality and mental health may be worth 
it to maintain a high level of HRQoL in chronic HF 
conditions.
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